Every SEC Form 3/4/5 on record for this filer (CIK 1879013) — 1 issuer, 89 transactions. Section-16 filings only: what they filed, not a biography, and titles are as filed on their latest form at each issuer.
| Ticker | Company | Role as filed | On file | Forms | Open-market net |
|---|---|---|---|---|---|
| CORT | CORCEPT THERAPEUTICS INC | Chief Development Officer | 2021-08-19 → 2026-06-04 | 45 | −$25M |
| Ticker | Date | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| CORT | 2026-06-02 | Sell | 20,000 | $70.60 | $1M | 3,985 |
| CORT | 2026-05-05 | Sell | 20,000 | $51.83 | $1M | 2,231 |
| CORT | 2026-04-07 | Sell | 20,000 | $40.97 | $819,400 | 2,231 |
| CORT | 2026-03-20 | Sell | 11,767 | $36.01 | $423,730 | 2,231 |
1 of 1 issuers are covered and open a security page; the rest are on file here only.